14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?

      1
      Psychiatric services (Washington, D.C.)
      American Psychiatric Publishing

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Major policy efforts are being aimed at combating the epidemic of opioid addiction and overdose deaths. In response to the epidemic, the medical community and policy makers have attempted to intervene; to date, these varied approaches have done little to reverse the increase in mortality related to opioid overdose. One factor that has complicated efforts to control overdose deaths has been the emergence of a public health crisis related to illicit fentanyl. The rise in fentanyl-related overdose deaths means that new approaches are needed to combat the opioid epidemic, including adoption of harm reduction strategies. Specific strategies that should be considered as part of efforts to combat the opioid crisis include safe drug consumption sites, anonymous drug-checking services, updated naloxone distribution policies, harm reduction-oriented policing, expansion of evidence-based pharmacological treatments in criminal justice and emergency department settings, and stigma-reduction messaging emphasizing the risks of fentanyl.

          Related collections

          Author and article information

          Journal
          Psychiatr Serv
          Psychiatric services (Washington, D.C.)
          American Psychiatric Publishing
          1557-9700
          1075-2730
          Jan 01 2018
          : 69
          : 1
          Affiliations
          [1 ] Dr. Barry is the Fred and Julie Soper Professor and Chair of the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore.
          Article
          10.1176/appi.ps.201700235
          28967324
          9a80093d-926a-4342-90f7-d4fb091eb251
          History

          Comments

          Comment on this article